Integer Holdings Co. (NASDAQ:ITGR)’s share price hit a new 52-week low during mid-day trading on Monday . The company traded as low as $21.81 and last traded at $22.42, with a volume of 128,894 shares. The stock had previously closed at $22.19.

ITGR has been the topic of a number of research reports. Sterne Agee CRT restated a “buy” rating on shares of Integer Holdings in a research report on Monday, May 16th. Zacks Investment Research upgraded shares of Integer Holdings from a “sell” rating to a “hold” rating in a research report on Thursday, May 19th. Finally, TheStreet lowered shares of Integer Holdings from a “hold” rating to a “sell” rating in a research report on Friday, July 1st. Two research analysts have rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $57.00.

The company’s market capitalization is $708.42 million. The firm has a 50 day moving average of $0.00 and a 200 day moving average of $0.00.

Integer Holdings (NASDAQ:ITGR) last issued its quarterly earnings data on Thursday, July 28th. The company reported $0.56 EPS for the quarter, missing the Zacks’ consensus estimate of $0.70 by $0.14. During the same period in the prior year, the firm posted $0.73 EPS. The company earned $348.38 million during the quarter, compared to analysts’ expectations of $356.72 million. Integer Holdings’s revenue was up 99.2% compared to the same quarter last year. On average, analysts anticipate that Integer Holdings Co. will post $2.64 EPS for the current year.

Greatbatch, Inc is a developer and manufacturer of medical devices and components. The Company operates through two segments: Greatbatch Medical and QiG Group (QiG). Greatbatch Medical designs and manufactures products where the Company either owns the intellectual property or has unique manufacturing and assembly expertise.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.